Ipca Laboratories Q4 net profit down 27.11% at Rs 110.41 cr
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
The company reported standalone net profit of Rs 110.41 crore for the quarter ended March 31, 2022 as compared to Rs 151.48 crore in the same period last year, registering a year-on-year decline of 27.11 per cent. Net revenue of the company rose moderately by 12.25 per cent at Rs 1,168.45 crore in January-March quarter of this fiscal as against Rs 1,040.92 crore in the corresponding period last year.
During January-March quarter, operating expenses increased by 20.04 per cent to Rs 989.43 crore from Rs 824.28 crore in year ago period. Other Income dipped by 28.63 per cent at Rs 14.21 crore versus (Mar'21 Rs 19.91 crore). Operating Profit slipped by 17.37 per cent to Rs 179.02 crore as against Rs 216.64 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 26.38 per cent in March quarter. Interest grew by 38.96 per cent y-o-y to Rs 3.21 crore, while Taxation decreased by 20.39 per cent at Rs 27.22 crore (Mar'21 Rs 34.19 crore).
